Delivery Order SPE2DR25D3103-SPE2DR26F9P67
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector supplies, valued at $4,994.93 under a firm fixed-price contract type. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside delivery order represents a small-value pharmaceutical procurement fulfilled by AmerisourceBergen's corporate office, with performance at the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,116.42 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, issued on December 10, 2025, represents a competitive award with no set-aside designation and calls for completion by December 11, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical...
- The Defense Logistics Agency awarded a $5,327.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of September 12, 2025, represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework with DLA. This delivery order was competitively awarded with no set-aside designation, reflecting the company's established...
- The Defense Logistics Agency awarded a $3,763.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. The contract, which is non-set-aside and competitively awarded, calls for performance completion by June 25, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single-item pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,485.53 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on December 10, 2025, with completion due by December 11, 2025. This is a firm fixed price delivery order under a non-set-aside, competitively awarded contract. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.38 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a $2,524.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations. The delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $1,908.36 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, designated as a non-set-aside award, represents a competitive procurement action and will be completed by December 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sumatriptan 6 mg/0.5ml auto-injectors with a ceiling value of $12,080.19. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P67Delivery Order
The Defense Logistics Agency awarded a $3,587.40 delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units on December 15, 2025, with completion targeted for December 16, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a key distribution hub for federal healthcare supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's contract portfolio with DLA demonstrates significant capability in fulfilling competitive federal medical procurement requirements across multiple therapeutic domains, positioning the company as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/14/25 |